HUMHIGH SIGNALOPERATIONAL10-K

Humana experienced a dramatic 69% decline in operating cash flow to $921M alongside a significant membership drop from 16M to 15M medical benefit plan members, while maintaining revenue growth through higher premiums.

The massive operating cash flow decline combined with membership losses suggests deteriorating operational efficiency and potential margin compression despite revenue growth. The company appears to be generating less cash per dollar of revenue, which could indicate rising medical costs or other operational challenges that investors should monitor closely.

Comparing 2026-02-19 vs 2025-02-20View on EDGAR →
FINANCIAL ANALYSIS

Revenue grew a healthy 10.1% to $129.7B, but this was overshadowed by a severe 68.9% collapse in operating cash flow from $3.0B to $921M, forcing management to dramatically reduce share buybacks by 81.5% and build cash reserves (which nearly doubled to $4.2B). Rising interest expense (+22.9%) and SG&A costs (+12.8%) suggest margin pressure, with the overall picture indicating that while Humana is growing its top line, the business is generating significantly less cash and facing operational headwinds that required defensive cash positioning.

FINANCIAL STATEMENT CHANGES
Cash & Equivalents
Balance Sheet
+89.1%
$2.2B$4.2B

Cash position surged 89.1% — strong cash generation or capital raise providing significant financial cushion.

Share Buybacks
Cash Flow
-81.5%
$817.0M$151.0M

Buyback activity reduced 81.5% — capital being redeployed elsewhere or cash conservation underway.

Operating Cash Flow
Cash Flow
-68.9%
$3.0B$921.0M

Operating cash flow fell 68.9% — earnings quality concerns; investigate working capital changes and non-cash items.

Interest Expense
P&L
+22.9%
$401.0M$493.0M

Interest costs rose 22.9% — monitor debt levels and coverage ratio in rising rate environment.

SG&A Expense
P&L
+12.8%
$13.7B$15.4B

SG&A increased modestly — likely reflects growth-related hiring or sales expansion investment.

Revenue
P&L
+10.1%
$117.8B$129.7B

Revenue growing 10.1% — solid top-line momentum, watch margins for quality of growth.

LANGUAGE CHANGES
NEW — 2026-02-19
PRIOR — 2025-02-20
ADDED
These efforts are leading to a better quality of life for Medicare and Medicaid participants, families, individuals, military service personnel, and communities at large.
As of December 31, 2025, we had approximately 15 million members in our medical benefit plans, as well as approximately 4.7 million members in our specialty products.
During 2025, 83% of our total premiums and services revenue were derived from contracts with the federal government, including 14% derived from our individual Medicare Advantage contracts in Florida with the Centers for Medicare and Medicaid Services, or CMS, under which we provided health insurance coverage to approximately 1.0 million members as of December 31, 2025.
At December 31, 2025, we provided health insurance coverage under CMS contracts to approximately 5.2 million individual Medicare Advantage members, including approximately 1.0 million members in Florida.
These 7 Florida contracts accounted for premiums revenue of approximately $17.8 billion, which represented approximately 20% of our individual Medicare Advantage premiums revenue, or 14% of our consolidated premiums and services revenue for the year ended December 31, 2025.
All material contracts between Humana and CMS relating to our Medicare Advantage products have been renewed for 2026, and all of our product offerings filed with CMS and going to market for 2026 have been approved.
All material contracts between Humana and CMS relating to our Medicare stand-alone PDP products have been renewed for 2026, and all of our product offerings filed with CMS and going to market for 2026 have been approved.
Our primary care business operates these clinics primarily under the Conviva Senior Primary Care and CenterWell Senior Primary Care brands.
Our primary care business currently operates 350 primary care clinics and employs approximately 1,300 primary care providers.
Primary care serves approximately 491,100 patients, primarily under risk sharing arrangements with Humana Medicare Advantage health plans, third-party Medicare Advantage health plans and CMS administered risk sharing arrangements for Original Medicare.
REMOVED
These efforts are leading to a better quality of life for people with Medicare, Medicaid, families, individuals, military service personnel, and communities at large.
As of December 31, 2024, we had approximately 16 million members in our medical benefit plans, as well as approximately 5 million members in our specialty products.
During 2024, 85% of our total premiums and services revenue were derived from contracts with the federal government, including 14% derived from our individual Medicare Advantage contracts in Florida with the Centers for Medicare and Medicaid Services, or CMS, under which we provide health insurance coverage to approximately 924,800 members as of December 31, 2024.
At December 31, 2024, we provided health insurance coverage under CMS contracts to approximately 5,661,800 individual Medicare Advantage members, including approximately 924,800 members in Florida.
These 7 Florida contracts accounted for premiums revenue of approximately $16.4 billion, which represented approximately 19% of our individual Medicare Advantage premiums revenue, or 14% of our consolidated premiums and services revenue for the year ended December 31, 2024.
All material contracts between Humana and CMS relating to our Medicare Advantage products have been renewed for 2025, and all of our product offerings filed with CMS for 2025 have been approved.
All material contracts between Humana and CMS relating to our Medicare stand-alone PDP products have been renewed for 2025, and all of our product offerings filed with CMS for 2025 have been approved.
Commercial Fully-Insured and ASO In February 2023, we announced our planned exit from the Employer Group Commercial Medical Products business, which includes all fully insured, self-funded and Federal Employee Health Benefit medical plans, as well as associated wellness and rewards programs.
Following a strategic review, we determined the Employer Group Commercial Medical Products business was no longer positioned to sustainably meet the needs of commercial members over the long term or support our long-term strategic plans.
We anticipate the exit of this line of business to be finalized in the first half of 2025.
MORE OPERATIONAL SIGNALS
NVDAHIGHNVIDIA has repositioned itself from a "full-stack computing infrastructure compa...
2026-02-25
NVDAHIGHNVIDIA has repositioned itself from a "full-stack computing infrastructure compa...
2026-02-25
NOWHIGHServiceNow has fundamentally repositioned itself as an AI-first platform company...
2026-01-29
TSLAHIGHTesla has fundamentally repositioned itself from an electric vehicle company to ...
2026-01-29
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →